Showing results (1101-1110 of 3,886) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|March 8, 2021
YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2Zhen Yang, Hongjian Ding, Zhiyu Pan, et al.Cancer Biology & Therapy|February 23, 2021
Silencing of LINC00284 inhibits cell proliferation and migration in oral squamous cell carcinoma by the miR-211-3p/MAFG axis and FUS/KAZN axisDayong Yan, Fuhua Wu, Caixia Peng, et al.Cancer Biology & Therapy|October 31, 2022
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA18Hairun Gan, Luting Li, Xinyan Hu, et al.Cancer Biology & Therapy|July 16, 2015
Use of vemurafenib in anaplastic thyroid carcinoma: a case reportKristen A Marten, Vinay K GudenaCancer Biology & Therapy|July 16, 2015
A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinomaOsamu Maehara, Fumiyuki Sato, Mitsuteru Natsuizaka, et al.Cancer Biology & Therapy|July 16, 2015
Pixantrone induces cell death through mitotic perturbations and subsequent aberrant cell divisionsNeil Beeharry, Andrea Ghelli Luserna Di Rora, Mitchell R Smith, et al.Cancer Biology & Therapy|July 16, 2015
KIFC1 is a novel potential therapeutic target for breast cancerYonghe Li, Wenyan Lu, Dongquan Chen, et al.Cancer Biology & Therapy|July 17, 2015
Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiationSeema Gupta, Huma Khan, Vandana Singh Kushwaha, et al.Cancer Biology & Therapy|July 17, 2015
Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapySandra Höfflin, Sabrina Prommersberger, Ugur Uslu, et al.Cancer Biology & Therapy|July 21, 2015
Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathway in vitro and in vivoHong-Fei Du, Li-Ping Ou, Chang-Kun Lv, et al.Pageof 389